Elaia is an independent venture capital firm, focused on the digital economy and deep tech. With over €700m under management, Elaia invests in high-potential disruptive startups from the first financing rounds to the emergence of global leaders. With more than 75 years of cumulated experience in both venture capital and digital industries, the investment team offers close, proactive, and relevant support to its entrepreneurs. Elaia was founded in 2002 by Philippe Gire and Xavier Lazarus and is based in Paris, Ile-de-France, France.

Elaia

iBionext is a unique healthcare fund created within a proven breakthrough innovation accelerator. Their companies are based in a single location named “Passage de l’innovation” in Paris, France. Over the past 4 years, we have created 7 companies that have raised over 250M € and created 103 highly qualified jobs.

iBionext

SWEN Capital Partners, a subsidiary of OFI AM and Federal Finance Gestion (FFG), is a reference in Responsible Investments, investing in private equity, private debt and private infrastructure, mainly in Europe.   With over €3 billion under management, SWEN Capital Partners offers to its clients an investment consulting service as well as the administration and portfolio monitoring of their historical allocations in the private market.   The team is composed by 20 people, most of them having worked together for the last 10 years, and having an excellent networking in the insurance financial market in France. SWEN Capital Partners aims to continue its commitment to responsible investing by integrating Environmental, Social and Governance (ESG) criteria in its selection, investment and reporting process.

Swen Capital Partners

Matmut Innovation is a venture capital firm in France that focuses on property and personal insurance products and financial services.

Matmut Innovation

CapHorn Invest is an independent Venture Capital Firm launched in 2010. The company invests in the climate and health sector. CapHorn Invest currently manages 180 million euros across two funds and has a portfolio of more than 20 companies.  Since 2020, the company operates as a Club Deal under the financial structure of Anaxago.  They invest in transformative technologies that help in the global effort against climate change. They mainly focus on seed to Serie B in rounds ranging from 1 to 10M€.

CapHorn Invest

Thea Laboratories is a pharmaceutical company that focuses on specializing in ophthalmology. It develops, manufactures, and researches on products that provides treatment and prevention on sickness of the eyes. Thea Laboratories was founded in 1994 and is based in Clermont-Ferrand, France.

Laboratoires Théa

Matmut is a financial company that offers a full range of property and personal insurance products (car, motorcycle, home, boat, hunting, responsibilities, protection of the family, health, welfare, legal protection, assistance) and financial services. The company was founded in 1961 and is based in Rouen, France.

Matmut

Adelie is a Paris & London based venture capital fund launched in 2019 to finance fast growing technology companies across Europe with a focus on Series A & B. The fund benefits from a large base of experienced entrepreneur investors and a partnership with Clipperton, a pan-European tech investment banking platform

Adelie

Tilak Healthcare

Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases.

Tilak Healthcare is developing mobile games with medical modules to monitor and treat patients with chronic conditions. The company has developed OdySight, the first remote monitoring system for age-related vision impairments, particularly macular degeneration, combined with a mobile gaming interface. The application is available on a prescription basis.

Membership-based, non-insurance healthcare companies helping maintain a steady state of well being.

Preventive Healthcare

Tilak Healthcare Strengthens Its Leadership Team

Novartis

Tilak Healthcare, a video game studio specializing in mobile medical games for patients with chronic diseases, enters into an exclusive co-promotion partnership with Novartis France for OdySight, its first clinically validated mobile game to monitor vision remotely.

Companies offer B2B and D2C evidence-based treatments delivered via software programs to prevent and manage a variety of chronic conditions.

Tilak Healthcare is developing mobile games with medical modules to monitor and treat patients with chronic conditions. The company has developed OdySight, the first remote monitoring system for age-related vision impairments, particularly macular degeneration, combined with a mobile gaming interface. The application is available on a prescription basis.The company operates a B2B2C business model offering its solution via healthcare providers. As of November 2023, the CE-marked platform had improved the care of 12,000 patients with retinal diseases in Europe and the US and allowed ophthalmologists to monitor patients' visual acuity in real time.Key customers and partnershipsThe company has several key partners, including BioNext, Biome, and PlugandPlay. Since December 2020, the company had partnered with Novartis to expand its product to international markets.Funding and financialsIn October 2023, the company raised EUR 10 million (USD 10.5 million) in a <a href="https://sp-edge.com/updates/22687">funding round </a>led by Elaia and Cap Horn. The funds were used to accelerate the rollout of its remote monitoring system for ophthalmic conditions in France and other countries. The company also had plans to develop new solutions for other medical conditions.

Cardiomo Care is developing noninvasive wearable devices to alert users and caretakers when there are abnormalities in the heartbeat. The company’s AI engine, trained on existing and growing data sets, can predict potential heart issues up to two hours before they occur, enabling early detection and intervention for arrhythmias and other cardiovascular diseases (CVDs).The company's product, CardiomoPatch, is a waterproof, wearable patch capable of long-term wear with a 10-day battery life. The patch monitors a patient's cardiac data, including ECG outputs, breathing, and skin temperature, and transmits the data via a mobile app for analysis by Cardiomo's AI engine.&nbsp;As of May 2024, the company is yet to commercialize its product and has over 1,600 pre-orders.

Cardiomo Care

Omada is a prevention-focused digital therapeutics startup that helps members achieve health goals through lifestyle changes. It offers four evidence-based, virtual prevention programs for managing hypertension, musculoskeletal (MSK) issues, prediabetes, and diabetes.Omada offers real-time data tracking through connected devices (such as wireless scales, blood pressure, and glucose monitors) and access to personalized coaching sessions via a mobile app as part of its prevention program. It also provides an online community of peers with similar health conditions to discuss challenges and provide support. In May 2021, Omada became the first fully-virtual healthcare provider to earn the National Committee for Quality Assurance’s Population Health Program Accreditation for its type 2 diabetes and type 2 diabetes + hypertension programs.Unlike its peers, Omada operates a performance-based business model where it charges clients an enrollment fee based on the number of users and a performance fee based on how much weight their employees lose. In May 2020, the company acquired virtual physical therapy startup Physera.Key customers and partnershipsAs of May 2024, Omada had more than 1 million members from more than 1,900 enterprise clients across all 50 US states. Its B2B employer and health plan client base include key clients such as American Eagle, Kaiser Permanente, Costco Wholesale, 3M, and Marvin. Additionally, the company has partnered with health systems and hospitals such as Intermountain Healthcare to provide its preventive programs as a covered benefit.In <a href="https://sp-edge.com/updates/15587">January 2023</a>, the company partnered with health service company Castell (a subsidiary of Intermountain Healthcare) to provide its diabetes programs to members from Intermountain Healthcare’s primary care providers in its Utah Medical Group. Further in <a href="https://sp-edge.com/updates/25245">January 2024</a>, the company partnered with Amazon to expand access to its cardiometabolic program.

Omada Health

VillageMD provides primary care services for patients. It also provides tools, technology, and staffing support needed for physicians to deliver high-quality services. VillageMD’s service delivery methods include traditional freestanding clinics, Village Medical at Walgreens co-located clinics, as well as at-home and around-the-clock virtual visits. It also leverages a team-based approach to care where physicians lead nurse practitioners, pharmacists, mental health specialists, and dietitians to offer a holistic care program. The technology of VillageMD includes docOS, an operating system that enables better patient care by connecting various clinical source systems with ongoing patient-generated data coupled with an AI engine to continuously analyze messages to enable patient self-care.The company made several acquisitions to expand its footprint: 1) <a href="https://sp-edge.com/updates/14347">Summit Health</a> for USD 8.9 billion in November 2022, 2) Healthy Interactions, an interactive patient education platform, in February 2022, and 3) <a href="https://sp-edge.com/updates/16968">Starling Physicians</a>, a primary care and specialty care provider, in March 2023.Key customers and partnershipsIn June 2020, VillageMD and Walgreens Boots Alliance announced a collaborative effort to open at least 600 Village Medical centers at Walgreens across more than 30 US markets by 2025. Walgreens invested USD 5.2 billion in VillageMD (from the previously announced USD 1.0 billion), raising its ownership stake to 63% (from 30%).However, as of May 2024, Walgreens had plans to close 160 VillageMD clinics as part of a cost-cutting plan.

VillageMD

Cityblock Health is a value-based healthcare provider focused on delivering comprehensive care to underserved communities, primarily Medicaid and lower-income Medicare beneficiaries. The company combines primary care, behavioral health, and social services to address the complex physical, mental, and social needs of its members.Cityblock's model involves partnering with local community-based organizations and deploying multidisciplinary care teams that include doctors, nurses, behavioral health specialists, and community health workers. These teams provide personalized care through 24/7 access to multi-modal care delivery, including in-home visits, telehealth, and community health hubs.The services of Cityblock are available to members at no additional cost if they are covered by an eligible health plan.Key Customers and PartnershipsAs of May 2024, the company’s services were available in seven states across the US and served over 100,000 members.In May 2024, it partnered with <a href="https://sp-edge.com/updates/29647">Sunshine Health</a> to expand to Florida, and, in <a href="https://sp-edge.com/updates/13270">September 2022</a>, it partnered with MDwise to expand into Indiana. Prior to that, the company had partnered with insurance providers such as ConnectiCare (Connecticut), Tufts Health Plan (Massachusetts), Emblem Health (New York), Healthy Blue (North Carolina), Molina Healthcare (Ohio) and CareFirst (Washington DC).Funding and FinancialsCityblock is a spin-off of Sidewalk Labs, an Alphabet company that incubates and invests in tech companies and products to improve urban infrastructure. It completed a USD 400 million Series D funding round led by Softbank in <a href="https://sp-edge.com/updates/5326">September 2021</a>, valuing the company at USD 5.7 billion. The funds were used to expand its services.

Cityblock Health

Everside Health (formerly Paladina Health) offers preventative care for chronic conditions and primary, mental and occupational healthcare treatments for acute conditions. Patients benefit from around-the-clock access to care, same-day or next-day appointments for in-person, and virtual care visits with zero copays.Everside aims to generate around 17% healthcare cost savings in three years and 31% in five years for its corporate members by leveraging a data-driven approach to care coordination.The company leverages data from past medical records, predictive analytics, and AI in the delivery of preventative care services.Founded in 2010 under the name Paladina Health, the company was rebranded in November 2020 as Everside Health following a merger between three primary care groups (Paladina, Activate Healthcare, and Healthstat). Furthermore, in February 2024, Everside Health merged with primary care provider Marathon Health to form a combined entity that would operate as Marathon Health, and, as of May 2024, the integration was ongoing.Key customers and partnershipPost-merger with Marathon Health, the combined entity would serve 2.5 million patients through over 680 clinics across 41 states.Funding and financialsThe company received its most recent investment in July 2022, amounting to USD 164 million in growth equity funding. The round was led by New Enterprise Associates (NEA). The funds were allocated toward growing its market presence and exploring opportunities for M&amp;A as well as to enhance and improve its product features. Additionally, the firm planned to expand its coverage of specialty care services aimed at individuals, employers, and union organizations.

Everside Health

Platforms offer a subscription-based or B2B-sponsored, evidence-based program for managing a specific long-term health condition.

DPCs offer value-based primary and preventive care services addressing whole-person (social, mental, physical) needs for a fixed monthly or annual fee paid by either the patient, insurance provider, or employer.

Tools that collect and analyze real-time patient data that supports healthcare providers with clinical decisions,  improves patient outcomes, and reduces medical errors.

Companies offer independent physician practices and hospitals with the tools (patient engagement, care coordination, administrative services) to help manage and improve clinical health outcomes of a defined group of individuals or large populations.

Platforms are used to track and gather patient health-related information via either a connected device or at-home test kits to detect the early onset of disease and identify any abnormalities in readings—but do not include a treatment plan.

To gather large amounts of real-time data for chronic care management, DTx, and patient monitoring

XR used by some startups for chronic pain management

Offers digital means of providing direct primary care, passive remote monitoring, chronic care management, etc.

AI/ML is used in predictive analytics, diagnostics tools, and population management

Offers tailored preventive interventions and treatments to the specific needs and characteristics of each individual

<div>
 
 <ul>
 <li>French digital health startup Tilak Healthcare has raised EUR 10 million (USD 10.5 million) in funding. The round was led by Elaia and Cap Horn, with participation from existing and new investors. This brings the company's total funding to EUR 22 million (USD 23.2 million) since its founding in 2016.</li>
 <li>The funds will be used to accelerate the rollout of OdySight, Tilak Healthcare's remote monitoring system for ophthalmic conditions, in France and abroad. The company also plans to develop new solutions for other medical conditions.</li>
 <li>OdySight is the first remote monitoring system for age-related vision impairments, specifically macular degeneration, combined with a mobile gaming interface. It has improved the care of 12,000 patients suffering from retinal diseases in Europe and the US. The platform allows ophthalmologists to monitor patients' visual acuity in real-time.&nbsp;</li>
 </ul>
 
</div>

Tilak Healthcare

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless